Performance evaluation of antibody-based point-of-care devices intended for the identification of immune responses to SARS-CoV-2

The novel coronavirus outbreak caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2) was first identified in December of 2019 in Wuhan, China. The local outbreak quickly rose to pandemic level that has spread to more than 188 countries with more than 19 million cases and 732,467 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Furuya, Andrea K.M., Wagner, Christine, Connors, Julia, Bodnar, Janine, Miller, Thomas, Ryman, Nko Lea, Warszycki, Casey J., Wong, Susan J., Walsh, Anne C., McDonough, Kathleen A., Lee, William T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758720/
https://www.ncbi.nlm.nih.gov/pubmed/33418405
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758720/
https://www.ncbi.nlm.nih.gov/pubmed/33418405
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115298

Ejemplares similares